Dr Oyepeju Folashade Abioye talks to ecancer about a study she presented at ASCO 2025.

Access to clinical trials remains a pillar of high-quality cancer care, however oncology research in sub-Saharan Africa is hindered by multifaceted barriers, limiting the development of effective, region-specific therapies. 

Strategies to address these barriers include investing in the training of healthcare professionals, providing adequate infrastructure, increasing funding through public-private partnerships, and enhancing community engagement to build trust and improve trial participation.